141 related articles for article (PubMed ID: 36181971)
1. Administration of the antiviral agent T-1105 fully protects pigs from foot-and-mouth disease infection.
Nishi T; Fukai K; Masujin K; Kawaguchi R; Ikezawa M; Yamada M; Nakajima N; Komeno T; Furuta Y; Sugihara H; Kurosaki C; Sakamoto K; Morioka K
Antiviral Res; 2022 Dec; 208():105425. PubMed ID: 36181971
[TBL] [Abstract][Full Text] [Related]
2. A Refined Guinea Pig Model of Foot-and-Mouth Disease Virus Infection for Assessing the Efficacy of Antiviral Compounds.
De Vleeschauwer AR; Lefebvre DJ; Willems T; Paul G; Billiet A; Murao LE; Neyts J; Goris N; De Clercq K
Transbound Emerg Dis; 2016 Apr; 63(2):e205-12. PubMed ID: 25164494
[TBL] [Abstract][Full Text] [Related]
3. BacMam Expressing Highly Glycosylated Porcine Interferon Alpha Induces Robust Antiviral and Adjuvant Effects against Foot-and-Mouth Disease Virus in Pigs.
Kim A; Lee G; Hwang JH; Park JH; Lee MJ; Kim B; Kim SM
J Virol; 2022 Jun; 96(12):e0052822. PubMed ID: 35604219
[TBL] [Abstract][Full Text] [Related]
4. Antiviral effect of vesatolimod (GS-9620) against foot-and-mouth disease virus both in vitro and invivo.
Lee G; Kang HR; Kim A; Park JH; Lee MJ; Kim SM
Antiviral Res; 2022 Sep; 205():105384. PubMed ID: 35863499
[TBL] [Abstract][Full Text] [Related]
5. Potent small molecule inhibitors against the 3C protease of foot-and-mouth disease virus.
Kim Y; Pool E; Kim E; Dampalla CS; Nguyen HN; Johnson DK; Lovell S; Groutas WC; Chang K-O
Microbiol Spectr; 2024 Apr; 12(4):e0337223. PubMed ID: 38466127
[TBL] [Abstract][Full Text] [Related]
6. Constitutively Active IRF7/IRF3 Fusion Protein Completely Protects Swine against Foot-and-Mouth Disease.
Ramírez-Carvajal L; Diaz-San Segundo F; Ramirez-Medina E; Rodríguez LL; de Los Santos T
J Virol; 2016 Oct; 90(19):8809-21. PubMed ID: 27466421
[TBL] [Abstract][Full Text] [Related]
7. Antiviral Effect of Manganese against Foot-and-Mouth Disease Virus Both in PK15 Cells and Mice.
Zhang Z; Zhang R; Yin J; Zhao S; Qin X; Chen F; Yang Y; Bai L; Guo Z; Wu Y; Li Y; Zhang Z
Viruses; 2023 Jan; 15(2):. PubMed ID: 36851604
[TBL] [Abstract][Full Text] [Related]
8. In Vitro and in Vivo Antiviral Activity of Mizoribine Against Foot-And-Mouth Disease Virus.
Li SF; Gong MJ; Sun YF; Shao JJ; Zhang YG; Chang HY
Molecules; 2019 May; 24(9):. PubMed ID: 31058822
[TBL] [Abstract][Full Text] [Related]
9. Antiviral activity of brequinar against foot-and-mouth disease virus infection in vitro and in vivo.
Li SF; Gong MJ; Sun YF; Shao JJ; Zhang YG; Chang HY
Biomed Pharmacother; 2019 Aug; 116():108982. PubMed ID: 31146110
[TBL] [Abstract][Full Text] [Related]
10. Lithium chloride inhibits early stages of foot-and-mouth disease virus (FMDV) replication in vitro.
Zhao FR; Xie YL; Liu ZZ; Shao JJ; Li SF; Zhang YG; Chang HY
J Med Virol; 2017 Nov; 89(11):2041-2046. PubMed ID: 28390158
[TBL] [Abstract][Full Text] [Related]
11. Coinjection of a vaccine and anti-viral agents can provide fast-acting protection from foot-and-mouth disease.
You SH; Kim T; Choi JH; Park G; Lee KN; Kim B; Lee MH; Kim HS; Kim SM; Park JH
Antiviral Res; 2017 Jul; 143():195-204. PubMed ID: 28454913
[TBL] [Abstract][Full Text] [Related]
12. Improved foot-and-mouth disease vaccine, O TWN-R, protects pigs against SEA topotype virus occurred in South Korea.
Choi JH; Ko MK; Shin SH; You SH; Jo HE; Jo H; Lee MJ; Kim SM; Lee JS; Kim B; Park JH
Vet Microbiol; 2019 Sep; 236():108374. PubMed ID: 31500734
[TBL] [Abstract][Full Text] [Related]
13. Antiviral activity of merimepodib against foot and mouth disease virus in vitro and in vivo.
Li SF; Gong MJ; Shao JJ; Sun YF; Zhang YG; Chang HY
Mol Immunol; 2019 Oct; 114():226-232. PubMed ID: 31386979
[TBL] [Abstract][Full Text] [Related]
14. The Pseudoknot Region of the 5' Untranslated Region Is a Determinant of Viral Tropism and Virulence of Foot-and-Mouth Disease Virus.
Zhu Z; Yang F; Cao W; Liu H; Zhang K; Tian H; Dang W; He J; Guo J; Liu X; Zheng H
J Virol; 2019 Apr; 93(8):. PubMed ID: 30728251
[TBL] [Abstract][Full Text] [Related]
15. Cross-protective efficacy of engineering serotype A foot-and-mouth disease virus vaccine against the two pandemic strains in swine.
Zheng H; Lian K; Yang F; Jin Y; Zhu Z; Guo J; Cao W; Liu H; He J; Zhang K; Li D; Liu X
Vaccine; 2015 Oct; 33(43):5772-5778. PubMed ID: 26431990
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effect of ribavirin and vaccine for protection during early infection stage of foot-and-mouth disease.
Choi JH; Jeong K; Kim SM; Ko MK; You SH; Lyoo YS; Kim B; Ku JM; Park JH
J Vet Sci; 2018 Nov; 19(6):788-797. PubMed ID: 30304889
[TBL] [Abstract][Full Text] [Related]
17. Rapid Engineering of Foot-and-Mouth Disease Vaccine and Challenge Viruses.
Lee SY; Lee YJ; Kim RH; Park JN; Park ME; Ko MK; Choi JH; Chu JQ; Lee KN; Kim SM; Tark D; Lee HS; Ko YJ; Seo MG; Park JW; Kim B; Lee MH; Lee JS; Park JH
J Virol; 2017 Aug; 91(16):. PubMed ID: 28566375
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of cross-protection against three topotypes of serotype O foot-and-mouth disease virus in pigs vaccinated with multi-epitope protein vaccine incorporated with poly(I:C).
Cao Y; Lu Z; Li D; Fan P; Sun P; Bao H; Fu Y; Li P; Bai X; Chen Y; Xie B; Liu Z
Vet Microbiol; 2014 Jan; 168(2-4):294-301. PubMed ID: 24345411
[TBL] [Abstract][Full Text] [Related]
19. Porcine interferon-α linked to the porcine IgG-Fc induces prolonged and broad-spectrum antiviral effects against foot-and-mouth disease virus.
Lee G; Kim A; Kang HR; Hwang JH; Park JH; Lee MJ; Kim B; Kim SM
Antiviral Res; 2024 Mar; 223():105836. PubMed ID: 38360296
[TBL] [Abstract][Full Text] [Related]
20. Detection of Foot-and-mouth Disease Virus RNA and Capsid Protein in Lymphoid Tissues of Convalescent Pigs Does Not Indicate Existence of a Carrier State.
Stenfeldt C; Pacheco JM; Smoliga GR; Bishop E; Pauszek SJ; Hartwig EJ; Rodriguez LL; Arzt J
Transbound Emerg Dis; 2016 Apr; 63(2):152-64. PubMed ID: 24943477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
